Pancreatic ductal adenocarcinoma (PDAC) is a notoriously lethal disease characterized by prominent stromal involvement, which plays complex roles in regulating tumor growth and therapeutic response. The extracellular matrix (ECM)-rich stroma has been implicated as a barrier to drug penetration, although stromal depletion strategies have had mixed clinical success. It remains less clear how biophysical interactions with the ECM regulate invasive progression and susceptibilities to specific therapies. Here, an integrative approach combining 3D cell culture and quantitative imaging techniques is used to evaluate invasive behavior and motility as determinants of response to classical chemotherapy and photodynamic therapy (PDT), in which light a...
Pancreatic ductal adenocarcinoma (PDAC) has an extraordinarily dense fibrotic stroma that impedes tu...
The tumor microenvironment (TME) governs all aspects of cancer progression and in vitro 3D cell cult...
Epithelial-to-mesenchymal transition (EMT) is a step-wise process leading to the phenotypic switch o...
Pancreatic ductal adenocarcinoma (PDAC) is a notoriously lethal disease characterized by prominent s...
The tumor microenvironment influences cancer cell behavior in relation to tumor progression, as well...
Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal cancers. Its aggressiveness is dri...
Abstract: The extracellular matrix (ECM) in the tumor microenvironment modulates the cancer cell phe...
Over 80% of patients with pancreatic ductal adenocarcinoma (PDAC) are diagnosed at a late stage and ...
Pancreatic ductal adenocarcinoma (PDAC) is a highly malignant disease with a very poor prognosis, du...
Cancer is a complex disease in which growth and progression is governed by biological as well as phy...
Metastasis, the spread of cancer cells from the primary tumour to a secondary site, requires biochem...
Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive cancer that is a leading cause of can...
Cancer is a complex and lethal disease, whose behavior is determined by biological, chemical, and ph...
Pancreatic ductal adenocarcinoma (PDAC) is notorious for a dense fibrotic stroma that is interlaced ...
Patient-derived in vivo models of human cancer have become a reality, yet their turnaround time is i...
Pancreatic ductal adenocarcinoma (PDAC) has an extraordinarily dense fibrotic stroma that impedes tu...
The tumor microenvironment (TME) governs all aspects of cancer progression and in vitro 3D cell cult...
Epithelial-to-mesenchymal transition (EMT) is a step-wise process leading to the phenotypic switch o...
Pancreatic ductal adenocarcinoma (PDAC) is a notoriously lethal disease characterized by prominent s...
The tumor microenvironment influences cancer cell behavior in relation to tumor progression, as well...
Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal cancers. Its aggressiveness is dri...
Abstract: The extracellular matrix (ECM) in the tumor microenvironment modulates the cancer cell phe...
Over 80% of patients with pancreatic ductal adenocarcinoma (PDAC) are diagnosed at a late stage and ...
Pancreatic ductal adenocarcinoma (PDAC) is a highly malignant disease with a very poor prognosis, du...
Cancer is a complex disease in which growth and progression is governed by biological as well as phy...
Metastasis, the spread of cancer cells from the primary tumour to a secondary site, requires biochem...
Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive cancer that is a leading cause of can...
Cancer is a complex and lethal disease, whose behavior is determined by biological, chemical, and ph...
Pancreatic ductal adenocarcinoma (PDAC) is notorious for a dense fibrotic stroma that is interlaced ...
Patient-derived in vivo models of human cancer have become a reality, yet their turnaround time is i...
Pancreatic ductal adenocarcinoma (PDAC) has an extraordinarily dense fibrotic stroma that impedes tu...
The tumor microenvironment (TME) governs all aspects of cancer progression and in vitro 3D cell cult...
Epithelial-to-mesenchymal transition (EMT) is a step-wise process leading to the phenotypic switch o...